In-House Counsel Guarding Against Expanded Liability: On-Demand #MCLE

Steve Imbriglia

SCOTUS will soon decide if state law failure-to-warn claims against generic drug manufacturers are preempted. Meanwhile, plaintiffs are arguing that pharmaceutical companies should be responsible for inadequacies in the warnings on products sold by generics. Can your company be responsible for the labeling on another company's product? Sound impossible? Trial lawyer Steve Imbriglia will discuss the issue before the Supreme Court, its implications and attempts to expand failure-to-warn liability.
Title:
In-House Counsel Guarding Against Expanded Liability
When/Where:
On-Demand Recording
Speaker:
Stephen J. Imbriglia is the Administrative Director in charge of Gibbons PC’s Philadelphia Office. Mr. Imbriglia is a trial lawyer who concentrates his practice in the defense of product liability cases. He defends pharmaceutical and medical-device manufacturers. For more than twenty years, Mr. Imbriglia has also defended companies in toxic tort litigation, such as those involving exposures to asbestos, benzene, beryllium and lead. In addition to defending clients in individual cases, he has extensive experience representing companies in class actions, multidistrict litigation and serial lawsuits. Mr. Imbriglia has served as national and local counsel for companies in mass tort litigation.
Mr. Imbriglia also defends professionals, including architects, engineers and accountants, in professional-liability actions.
Mr. Imbriglia has authored articles about medical monitoring claims, Daubert issues, class actions and mass tort litigation.
A Philadelphia native, Mr. Imbriglia began his career as a prosecutor in the Philadelphia District Attorney’s Office before transitioning to civil litigation.
Sponsor:
Trial.com
Credit:
.25 CLE Credit Hours Available for AK AZ CA CO FL GA HI IN KY LA MO ND NJ NY TX UT WA
More:
http://www.trial.com/cle/courses/2011-fl/imbriglia.html